JP2014517004A - 複素環スルホンアミド誘導体 - Google Patents
複素環スルホンアミド誘導体 Download PDFInfo
- Publication number
- JP2014517004A JP2014517004A JP2014514204A JP2014514204A JP2014517004A JP 2014517004 A JP2014517004 A JP 2014517004A JP 2014514204 A JP2014514204 A JP 2014514204A JP 2014514204 A JP2014514204 A JP 2014514204A JP 2014517004 A JP2014517004 A JP 2014517004A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compounds
- fluoro
- difluoro
- iodophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c(c(Nc(c(F)c1)ccc1I)c1F)c2[o]ccc2c1F Chemical compound *c(c(Nc(c(F)c1)ccc1I)c1F)c2[o]ccc2c1F 0.000 description 1
- HDCNGHWMQZINND-UHFFFAOYSA-N C=CCC1(CC1)S(N(c(c([o]cc1)c1c(F)c1F)c1N1c(c(F)c2)ccc2I)C1=O)=O Chemical compound C=CCC1(CC1)S(N(c(c([o]cc1)c1c(F)c1F)c1N1c(c(F)c2)ccc2I)C1=O)=O HDCNGHWMQZINND-UHFFFAOYSA-N 0.000 description 1
- WXDSPHCCPWBIEX-UHFFFAOYSA-N Nc(c(Nc(c(F)c1)ccc1I)c1F)c2[o]ccc2c1F Chemical compound Nc(c(Nc(c(F)c1)ccc1I)c1F)c2[o]ccc2c1F WXDSPHCCPWBIEX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1634DE2011 | 2011-06-09 | ||
IN1634/DEL/11 | 2011-06-09 | ||
CN201210175145 | 2012-05-31 | ||
CN201210175145.6 | 2012-05-31 | ||
PCT/IB2012/052860 WO2012168884A1 (en) | 2011-06-09 | 2012-06-06 | Heterocyclic sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2014517004A true JP2014517004A (ja) | 2014-07-17 |
Family
ID=46384435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014514204A Pending JP2014517004A (ja) | 2011-06-09 | 2012-06-06 | 複素環スルホンアミド誘導体 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2718276A1 (ru) |
JP (1) | JP2014517004A (ru) |
KR (1) | KR20140034898A (ru) |
AU (1) | AU2012265844A1 (ru) |
BR (1) | BR112013031201A2 (ru) |
CA (1) | CA2838029A1 (ru) |
EA (1) | EA201391820A1 (ru) |
IN (1) | IN2014DN00123A (ru) |
MX (1) | MX2013014398A (ru) |
WO (1) | WO2012168884A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020521741A (ja) * | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2796455A4 (en) * | 2011-12-19 | 2015-08-19 | Sumitomo Chemical Co | PROCESS FOR PRODUCING SULFONATE |
EP3251673A1 (en) | 2012-12-13 | 2017-12-06 | IP Gesellschaft für Management mbH | Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer |
CN104886052B (zh) * | 2015-06-02 | 2016-08-31 | 吉林省八达农药有限公司 | 一种环丙磺酰胺的应用 |
WO2019183385A1 (en) * | 2018-03-22 | 2019-09-26 | University Of Rochester | Mapk/erk inhibition for ovarian and other cancers |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006083137A (ja) * | 2004-09-17 | 2006-03-30 | Sankyo Co Ltd | 免疫抑制剤 |
WO2009018238A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |
WO2009112490A1 (en) * | 2008-03-11 | 2009-09-17 | Cellzome Limited | Sulfonamides as zap-70 inhibitors |
JP2010516698A (ja) * | 2007-01-19 | 2010-05-20 | アルデア バイオサイエンシズ,インコーポレイティド | Mekのインヒビター |
WO2010121646A1 (en) * | 2009-04-21 | 2010-10-28 | Novartis Ag | Heterocyclic compounds as mek inhibitors |
WO2010145197A1 (en) * | 2009-06-15 | 2010-12-23 | Chemizon (Beijing), Ltd. | Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
WO2011054828A1 (en) * | 2009-11-04 | 2011-05-12 | Novartis Ag | Heterocyclic sulfonamide derivatives useful as mek inhibitors |
JP2011526926A (ja) * | 2008-07-01 | 2011-10-20 | ジェネンテック, インコーポレイテッド | 置換二環式ヘテロ環化合物と使用方法 |
JP5456908B2 (ja) * | 2009-12-08 | 2014-04-02 | ノバルティス アーゲー | ヘテロ環式スルホンアミド誘導体 |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR901228A (fr) | 1943-01-16 | 1945-07-20 | Deutsche Edelstahlwerke Ag | Système d'aimant à entrefer annulaire |
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
US5395855A (en) | 1990-05-07 | 1995-03-07 | Ciba-Geigy Corporation | Hydrazones |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
TW225528B (ru) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
DE69233803D1 (de) | 1992-10-28 | 2011-03-31 | Genentech Inc | Verwendung von vaskulären Endothelwachstumsfaktor-Antagonisten |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
DE69536015D1 (de) | 1995-03-30 | 2009-12-10 | Pfizer Prod Inc | Chinazolinone Derivate |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
BR9609617B1 (pt) | 1995-07-06 | 2010-07-27 | derivados de 7h-pirrol[2,3-d]pirimidina, e composição farmacêutica. | |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
CA2249446C (en) | 1996-04-12 | 2008-06-17 | Warner-Lambert Company | Irreversible inhibitors of tyrosine kinases |
WO1997049688A1 (en) | 1996-06-24 | 1997-12-31 | Pfizer Inc. | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
JP2001500851A (ja) | 1996-08-30 | 2001-01-23 | ノバルティス アクチエンゲゼルシャフト | エポシロンの製造法および製造過程中に得られる中間生産物 |
EP0938597B1 (en) | 1996-09-06 | 2003-08-20 | Obducat Aktiebolag | Method for anisotropic etching of structures in conducting materials |
DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
CA2265630A1 (en) | 1996-09-13 | 1998-03-19 | Gerald Mcmahon | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
CN100344627C (zh) | 1996-11-18 | 2007-10-24 | 生物技术研究有限公司(Gbf) | 埃坡霉素c、其制备方法以及作为细胞抑制剂和植物保护剂的应用 |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
IL138113A0 (en) | 1998-02-25 | 2001-10-31 | Sloan Kettering Inst Cancer | Synthesis of epothilones, intermediates thereto and analogues thereof |
ES2342240T3 (es) | 1998-08-11 | 2010-07-02 | Novartis Ag | Derivados de isoquinolina con actividad que inhibe la angiogenia. |
UA71587C2 (ru) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Translated By PlajАМИДЫ АНТРАНИЛОВОЙ КИСЛОТЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕЧЕБНЫХ СРЕДСТВ |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
KR100716272B1 (ko) | 1998-11-20 | 2007-05-09 | 코산 바이오사이언시즈, 인코포레이티드 | 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질 |
EP1140173B2 (en) | 1998-12-22 | 2013-04-03 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists and uses thereof |
BR0009507A (pt) | 1999-03-30 | 2002-01-15 | Novartis Ag | Derivados de ftalazina para o tratamento de doenças inflamatórias |
PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
AR035885A1 (es) | 2001-05-14 | 2004-07-21 | Novartis Ag | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
-
2012
- 2012-06-06 MX MX2013014398A patent/MX2013014398A/es unknown
- 2012-06-06 BR BR112013031201A patent/BR112013031201A2/pt not_active IP Right Cessation
- 2012-06-06 KR KR1020147000283A patent/KR20140034898A/ko not_active Application Discontinuation
- 2012-06-06 WO PCT/IB2012/052860 patent/WO2012168884A1/en active Application Filing
- 2012-06-06 EP EP12730043.2A patent/EP2718276A1/en not_active Withdrawn
- 2012-06-06 AU AU2012265844A patent/AU2012265844A1/en not_active Abandoned
- 2012-06-06 CA CA2838029A patent/CA2838029A1/en not_active Abandoned
- 2012-06-06 EA EA201391820A patent/EA201391820A1/ru unknown
- 2012-06-06 JP JP2014514204A patent/JP2014517004A/ja active Pending
- 2012-06-06 IN IN123DEN2014 patent/IN2014DN00123A/en unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006083137A (ja) * | 2004-09-17 | 2006-03-30 | Sankyo Co Ltd | 免疫抑制剤 |
JP2010516698A (ja) * | 2007-01-19 | 2010-05-20 | アルデア バイオサイエンシズ,インコーポレイティド | Mekのインヒビター |
WO2009018238A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |
WO2009112490A1 (en) * | 2008-03-11 | 2009-09-17 | Cellzome Limited | Sulfonamides as zap-70 inhibitors |
JP2011526926A (ja) * | 2008-07-01 | 2011-10-20 | ジェネンテック, インコーポレイテッド | 置換二環式ヘテロ環化合物と使用方法 |
WO2010121646A1 (en) * | 2009-04-21 | 2010-10-28 | Novartis Ag | Heterocyclic compounds as mek inhibitors |
WO2010145197A1 (en) * | 2009-06-15 | 2010-12-23 | Chemizon (Beijing), Ltd. | Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
WO2011054828A1 (en) * | 2009-11-04 | 2011-05-12 | Novartis Ag | Heterocyclic sulfonamide derivatives useful as mek inhibitors |
JP5456908B2 (ja) * | 2009-12-08 | 2014-04-02 | ノバルティス アーゲー | ヘテロ環式スルホンアミド誘導体 |
Non-Patent Citations (1)
Title |
---|
JPN6016003369; 日本医薬品添加剤協会: 医薬品添加物事典2007 , 20070725, 189頁 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020521741A (ja) * | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20140034898A (ko) | 2014-03-20 |
BR112013031201A2 (pt) | 2017-01-31 |
IN2014DN00123A (ru) | 2015-05-22 |
EA201391820A1 (ru) | 2014-12-30 |
AU2012265844A1 (en) | 2013-05-02 |
EP2718276A1 (en) | 2014-04-16 |
CA2838029A1 (en) | 2012-12-13 |
WO2012168884A1 (en) | 2012-12-13 |
MX2013014398A (es) | 2014-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8969351B2 (en) | Crystalline form of an inhibitor of MDM2/4 and p53 interaction | |
US8466289B2 (en) | Heterocyclic sulfonamide derivatives | |
KR20120028882A (ko) | Mek 억제제로서의 헤테로시클릭 화합물 | |
JP5456908B2 (ja) | ヘテロ環式スルホンアミド誘導体 | |
JP2014517004A (ja) | 複素環スルホンアミド誘導体 | |
TW201038267A (en) | Heterocyclic compounds as MEK inhibitors | |
US8470878B2 (en) | Heterocyclic sulfonamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20140724 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20140724 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140813 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150603 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20151224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20160202 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160913 |